HU179745B - Process for preparing new phthalazine derivatives and pharmaceutical compositions containing these compounds - Google Patents

Process for preparing new phthalazine derivatives and pharmaceutical compositions containing these compounds Download PDF

Info

Publication number
HU179745B
HU179745B HU78PI629A HUPI000629A HU179745B HU 179745 B HU179745 B HU 179745B HU 78PI629 A HU78PI629 A HU 78PI629A HU PI000629 A HUPI000629 A HU PI000629A HU 179745 B HU179745 B HU 179745B
Authority
HU
Hungary
Prior art keywords
formula
alkyl
group
hydrogen
alkoxy
Prior art date
Application number
HU78PI629A
Other languages
English (en)
Hungarian (hu)
Inventor
Simon F Campbell
John C Danilewicz
S Anthony G Evan
Allan L Ham
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HU179745B publication Critical patent/HU179745B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU78PI629A 1977-06-03 1978-06-02 Process for preparing new phthalazine derivatives and pharmaceutical compositions containing these compounds HU179745B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2358277 1977-06-03

Publications (1)

Publication Number Publication Date
HU179745B true HU179745B (en) 1982-12-28

Family

ID=10198020

Family Applications (1)

Application Number Title Priority Date Filing Date
HU78PI629A HU179745B (en) 1977-06-03 1978-06-02 Process for preparing new phthalazine derivatives and pharmaceutical compositions containing these compounds

Country Status (29)

Country Link
US (1) US4289772A (en, 2012)
JP (1) JPS5416488A (en, 2012)
AR (2) AR222013A1 (en, 2012)
AT (2) AT362792B (en, 2012)
AU (1) AU505373B1 (en, 2012)
BE (1) BE867727A (en, 2012)
CA (1) CA1111850A (en, 2012)
DD (1) DD137355A5 (en, 2012)
DE (1) DE2824064A1 (en, 2012)
DK (1) DK248078A (en, 2012)
EG (1) EG13527A (en, 2012)
ES (4) ES470470A1 (en, 2012)
FI (1) FI781753A7 (en, 2012)
FR (1) FR2392986A1 (en, 2012)
GB (1) GB2000136B (en, 2012)
GR (1) GR74402B (en, 2012)
HU (1) HU179745B (en, 2012)
IL (1) IL54842A (en, 2012)
IN (3) IN148482B (en, 2012)
IT (1) IT1094944B (en, 2012)
LU (1) LU79761A1 (en, 2012)
NL (1) NL7806016A (en, 2012)
NO (1) NO781935L (en, 2012)
NZ (1) NZ187453A (en, 2012)
PL (3) PL116420B1 (en, 2012)
PT (1) PT68126A (en, 2012)
SE (1) SE7806519L (en, 2012)
SU (2) SU856383A3 (en, 2012)
ZA (1) ZA783183B (en, 2012)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
IL59619A0 (en) * 1979-03-28 1980-06-30 Pfizer Phthalazine derivatives,their preparation and pharmaceutical compositions containing them
PL128510B1 (en) * 1980-03-01 1984-02-29 Wyeth John & Brother Ltd Method of obtaining new piperidine derivatives
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
JP3169188B2 (ja) * 1991-01-31 2001-05-21 杏林製薬株式会社 カルバミン酸誘導体及びその製造方法
US5300515A (en) * 1991-01-31 1994-04-05 Kyorin Pharmaceutical Co., Ltd. Carbamic acid derivatives and method for preparing the same
EP0621267A1 (en) * 1993-04-07 1994-10-26 Shell Internationale Researchmaatschappij B.V. Spiropiperidine derivatives and their use as fungicides
US5728712A (en) * 1995-05-19 1998-03-17 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
CN1121220C (zh) * 1996-08-20 2003-09-17 卫材株式会社 稠合哒嗪系化合物的勃起机能不全症治疗剂
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
US20040224986A1 (en) 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
BR0313534A (pt) * 2002-08-16 2005-07-12 Janssen Pharmaceutica Nv Antagonistas de integrinade ácido carboxìlico de piperidinoìla
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
JP2009524637A (ja) * 2006-01-27 2009-07-02 ファイザー・プロダクツ・インク アミノフタラジン誘導体化合物
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007110449A1 (en) 2006-03-29 2007-10-04 Euro-Celtique S.A. Benzenesulfonamide compounds and their use
TW200815353A (en) 2006-04-13 2008-04-01 Euro Celtique Sa Benzenesulfonamide compounds and their use
WO2007118854A1 (en) 2006-04-13 2007-10-25 Euro-Celtique S.A. Benzenesulfonamide compounds and the use thereof
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP1903037A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors
EP1900731A1 (de) * 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8399486B2 (en) 2007-04-09 2013-03-19 Purdue Pharma L.P. Benzenesulfonyl compounds and the use thereof
ES2367464T3 (es) 2007-08-07 2011-11-03 F. Hoffmann-La Roche Ag Pirrolidina-aril-éteres como antagonistas de receptor de nk3.
CN101861302A (zh) 2007-08-22 2010-10-13 弗·哈夫曼-拉罗切有限公司 作为nk3受体拮抗剂的吡咯烷芳基-醚
EP2200982B1 (en) * 2007-09-14 2012-03-14 F. Hoffmann-La Roche AG Piperidine derivatives as nk3 receptor antagonists
WO2009040659A2 (en) 2007-09-28 2009-04-02 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AR077014A1 (es) * 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
EP4229828A4 (en) 2020-10-13 2024-08-28 Endeavor Biomedicines, Inc. METHODS OF TREATMENT OF FIBROSIS
CN113087654B (zh) * 2021-04-15 2022-12-23 苏州昊帆生物股份有限公司 哌啶-4-丁胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1094044A (en) * 1965-07-12 1967-12-06 Vantorex Ltd Phthalazine derivatives
GB1199768A (en) 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
GB1293565A (en) 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
GB1460389A (en) 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
NL7806016A (nl) 1978-12-05
NO781935L (no) 1978-12-05
ES478201A1 (es) 1980-02-01
ATA305080A (de) 1980-12-15
AR222013A1 (es) 1981-04-15
NZ187453A (en) 1980-12-19
IL54842A (en) 1982-01-31
FI781753A7 (fi) 1978-12-04
CA1111850A (en) 1981-11-03
PL116420B1 (en) 1981-06-30
SE7806519L (sv) 1978-12-04
ES470470A1 (es) 1979-09-01
IL54842A0 (en) 1978-08-31
PL113208B1 (en) 1980-11-29
GR74402B (en, 2012) 1984-06-28
EG13527A (en) 1981-12-31
ES478199A1 (es) 1980-01-16
IN149550B (en, 2012) 1982-01-16
LU79761A1 (fr) 1980-01-22
BE867727A (fr) 1978-12-01
JPS5416488A (en) 1979-02-07
ES478200A1 (es) 1980-01-01
AT363096B (de) 1981-07-10
DE2824064A1 (de) 1978-12-14
IN148482B (en, 2012) 1981-03-07
GB2000136A (en) 1979-01-04
AR223999A1 (es) 1981-10-15
IN149973B (en, 2012) 1982-06-19
PT68126A (en) 1978-07-01
IT7824106A0 (it) 1978-06-01
PL116437B1 (en) 1981-06-30
ATA400878A (de) 1980-11-15
FR2392986B1 (en, 2012) 1982-07-16
US4289772A (en) 1981-09-15
SU856383A3 (ru) 1981-08-15
DD137355A5 (de) 1979-08-29
DK248078A (da) 1978-12-04
ZA783183B (en) 1979-06-27
GB2000136B (en) 1982-01-06
AT362792B (de) 1981-06-10
AU505373B1 (en) 1979-11-15
IT1094944B (it) 1985-08-10
JPS5538351B2 (en, 2012) 1980-10-03
FR2392986A1 (fr) 1978-12-29
PL207337A1 (pl) 1979-06-04
SU862826A3 (ru) 1981-09-07

Similar Documents

Publication Publication Date Title
HU179745B (en) Process for preparing new phthalazine derivatives and pharmaceutical compositions containing these compounds
US4001422A (en) 4-aminoquinazoline cardiac stimulants
RU2024521C1 (ru) Производные дифенилметилимидазола или их фармацевтически приемлемые соли
US4686228A (en) Quinoline therapeutic agents
EP0025111B1 (en) 3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
BG107460A (bg) Производни на бензимидазола, тяхното получаване иприложението им в терапията
US4188391A (en) 4-[4-(Substituted)piperidino]quinazoline cardiac stimulants
DE3200304A1 (de) 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
EP0198456B1 (en) 1,7-naphthyridine derivatives and medicinal preparations containing same
US4518712A (en) Piperazine derivative and analgesic composition containing the same
EP0325406B1 (en) Diamine compounds
US4478837A (en) 3-Hydrazino cycloalkyl[c]pyridazines as antihypertensive agents
DE69012650T2 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
US4243666A (en) 4-Amino-2-piperidino-quinazolines
US4673682A (en) Isoquinoline derivatives, pharmaceutical formulations based on these compounds and the use thereof
US5635511A (en) Treatment of heart rhythm disorders by administration of 3-phenylsulfonyl-3,7-diazabicyclo[3.3.1]nonane compounds.
CS255877B2 (en) Process for preparing 1,2,4-triazolocarbamates
JPH033669B2 (en, 2012)
KR20030043970A (ko) 2,2-디페닐부탄아미드 유도체 및 이를 함유하는 의약
CH663616A5 (de) 1,4-dihydropyridin-derivate und sie enthaltende pharmazeutische zubereitungen.
EP0009608B1 (en) N-phenethylacetamide compounds, processes for their preparation and therapeutic compositions containing them
US3847923A (en) N-(1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carbonyloxy)succinimide and glutarimide
JPH0441149B2 (en, 2012)
CA1285945C (en) N-¬¬¬1-(2)naphthylenemethyl or quinol-6-ylmethyl)-4- piperidinyl|amino|-carbonyl|-6-quinolinecarboxamide compounds
CS229692B2 (en) Manufacturing process of derivate 4-phenylquinazoline